-+ 0.00%
-+ 0.00%
-+ 0.00%

AKTIS ONCOLOGY REPORTS FIRST-IN-HUMAN CLINICAL IMAGING AND DOSIMETRY DATA FOR AKY-2519 DEMONSTRATING ROBUST TUMOR UPTAKE AND LIMITED NORMAL TISSUE EXPOSURES IN PATIENTS WITH B7-H3 EXPRESSING TUMORS

Reuters·05/21/2026 21:21:08

Please log in to view news